Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Modeling compound-target interaction network of traditional Chinese medicines for type II diabetes mellitus: insight for polypharmacology and drug design.

Tian S, Li Y, Li D, Xu X, Wang J, Zhang Q, Hou T.

J Chem Inf Model. 2013 Jul 22;53(7):1787-803. doi: 10.1021/ci400146u. Epub 2013 Jun 26.

PMID:
23768230
2.

Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus.

Gu J, Zhang H, Chen L, Xu S, Yuan G, Xu X.

Comput Biol Chem. 2011 Oct 12;35(5):293-7. doi: 10.1016/j.compbiolchem.2011.07.003. Epub 2011 Jul 20.

PMID:
22000800
3.

In silico system pharmacology for the potential bioactive ingredients contained in Xingnaojing Injection () and Its material basis for sepsis treatment.

Ma ST, Feng CT, Xiong YX, Zhang XL, Miao CG, Yu H.

Chin J Integr Med. 2017 Oct 17. doi: 10.1007/s11655-017-2421-0. [Epub ahead of print]

PMID:
29039067
4.

Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.

Tian S, Sun H, Li Y, Pan P, Li D, Hou T.

J Chem Inf Model. 2013 Oct 28;53(10):2743-56. doi: 10.1021/ci400382r. Epub 2013 Sep 24.

PMID:
24010823
5.

Design of new traditional Chinese medicine herbal formulae for treatment of type 2 diabetes mellitus based on network pharmacology.

Hu RF, Sun XB.

Chin J Nat Med. 2017 Jun;15(6):436-441. doi: 10.1016/S1875-5364(17)30065-1.

PMID:
28629533
6.
7.

Addressing selective polypharmacology of antipsychotic drugs targeting the bioaminergic receptors through receptor dynamic conformational ensembles.

Selvam B, Porter SL, Tikhonova IG.

J Chem Inf Model. 2013 Jul 22;53(7):1761-74. doi: 10.1021/ci400282q. Epub 2013 Jul 5.

PMID:
23789628
8.

A combination of pharmacophore modeling, molecular docking and virtual screening for iNOS inhibitors from Chinese herbs.

Wang X, Ren Z, He Y, Xiang Y, Zhang Y, Qiao Y.

Biomed Mater Eng. 2014;24(1):1315-22. doi: 10.3233/BME-130934.

PMID:
24212027
9.

Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches.

Tian S, Wang J, Li Y, Xu X, Hou T.

Mol Pharm. 2012 Oct 1;9(10):2875-86. Epub 2012 Sep 20.

PMID:
22738405
10.

Diabetes is an inflammatory disease: evidence from traditional Chinese medicines.

Xie W, Du L.

Diabetes Obes Metab. 2011 Apr;13(4):289-301. doi: 10.1111/j.1463-1326.2010.01336.x. Review.

PMID:
21205111
11.

Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.

Meng H, Liu Y, Lai L.

Acc Chem Res. 2015 Aug 18;48(8):2242-50. doi: 10.1021/acs.accounts.5b00226. Epub 2015 Aug 3.

PMID:
26237215
12.

Insights into the inhibition and mechanism of compounds against LPS-induced PGE2 production: a pathway network-based approach and molecular dynamics simulations.

Zhang X, Gu J, Cao L, Ma Y, Su Z, Luo F, Wang Z, Li N, Yuan G, Chen L, Xu X, Xiao W.

Integr Biol (Camb). 2014 Dec;6(12):1162-9. doi: 10.1039/c4ib00141a. Epub 2014 Sep 17.

PMID:
25228393
13.

Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.

Chen KC, Chang SS, Huang HJ, Lin TL, Wu YJ, Chen CY.

J Biomol Struct Dyn. 2012;30(6):662-83. Epub 2012 Jun 26.

PMID:
22731403
14.

[Network pharmacology study of effective constituents of traditional Chinese medicine for Alzheimer’s disease treatment].

Pang XC, Wang Z, Fang JS, Lian WW, Zhao Y, Kang D, Liu AL, Du GH.

Yao Xue Xue Bao. 2016 May;51(5):725-31. Chinese.

PMID:
29874009
15.

Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.

Raskin P.

Diabetes Metab Res Rev. 2013 Jul;29(5):347-56. doi: 10.1002/dmrr.2403. Review.

PMID:
23463735
16.

Herb-target interaction network analysis helps to disclose molecular mechanism of traditional Chinese medicine.

Liang H, Ruan H, Ouyang Q, Lai L.

Sci Rep. 2016 Nov 11;6:36767. doi: 10.1038/srep36767.

17.

Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.

Liu H, Wang J, Zhou W, Wang Y, Yang L.

J Ethnopharmacol. 2013 Apr 19;146(3):773-93. doi: 10.1016/j.jep.2013.02.004. Epub 2013 Feb 14.

PMID:
23415946
18.

Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?

Chen KC, Chang SS, Tsai FJ, Chen CY.

J Biomol Struct Dyn. 2013;31(11):1219-35. doi: 10.1080/07391102.2012.732340. Epub 2012 Nov 12.

PMID:
23146021
19.
20.

Chemogenomics approaches to rationalizing the mode-of-action of traditional Chinese and Ayurvedic medicines.

Mohd Fauzi F, Koutsoukas A, Lowe R, Joshi K, Fan TP, Glen RC, Bender A.

J Chem Inf Model. 2013 Mar 25;53(3):661-73. doi: 10.1021/ci3005513. Epub 2013 Feb 18.

PMID:
23351136

Supplemental Content

Support Center